Study finds Zepbound cuts healthcare costs for older adults with obesity
Study shows sustained Zepbound use in older adults with obesity lowers costs, reinforcing the potential value of the Medicare GLP-1 Bridge program.
Zepbound
Ro launches Eli Lilly's KwikPen giving patients a more convenient way to take Zepbound
The most effective GLP-1 medication is now available in a multi-dose pen.